China CAR T Cell Therapy Market: Research Focus, Approvals, and the Commercialization Landscape
The China CAR T Cell Therapy Market is arguably the most rapidly advancing and competitive globally, distinguished by a massive volume of ongoing clinical trials and an aggressive approach to commercialization. The market is highly concentrated in the application of CAR T-cell therapies for various hematological cancers, building on the country's strong foundation in biotechnology and oncology research. The Chinese government has identified cell and gene therapy as a strategic priority, facilitating investment and accelerating regulatory review for innovative therapies.
4 Views
